logo
#

Latest news with #IanWalker

Cancer deaths cost UK economy £10bn a year
Cancer deaths cost UK economy £10bn a year

Telegraph

time6 days ago

  • Health
  • Telegraph

Cancer deaths cost UK economy £10bn a year

People dying early from cancer costs the UK economy £10.3 billion a year, according to the most comprehensive analysis of its kind. Researchers from Cancer Research UK calculated the number working years lost to the disease, alongside people's expected economic output in that time. They found that cancer deaths among young adults aged 25 to 49 were having a significant effect on overall economic output, costing £3.2 billion every year. When it comes to cancer type, lung cancer accounts for the biggest overall earning loss to the economy of £1.7 billion a year, with 54,000 total productive years of life lost. Bowel cancer accounts for £1.2 billion, with 39,000 years lost, while brain cancer accounts for £0.75 billion, and 26,000 years, and pancreatic £0.61 billion, and 20,000 years. The figures relate to lost earnings and do not include carer costs for looking after people with cancer or the cost of diagnosing or treating the disease. In an accompanying report, Cancer Research UK said improving cancer survival and catching the disease early could boost economic growth. In his foreword to the study, Ian Walker, the executive director of policy, argued that 'cancer isn't just a health challenge, but also an economic one'. He added: 'Current evidence shows that focusing on prevention and early detection and diagnosis is both the right thing to do for people affected by cancer, and the smart thing to do in economic terms.' Overall, each individual adult cancer death was found to cost an average of £61,000 to the economy. The impact was particularly big if people died when younger, owing to the larger loss in terms of working life. In 2023, some 119,000 years were taken from the future working lives of adults under 50, amounting to £3.2 billion in lost output. In the future, losses could grow even more as cancer cases and deaths are projected to rise, with half a million cases diagnosed every year by 2040. Michelle Mitchell, chief executive of Cancer Research UK, said: 'Cancer has an immeasurable impact on patients and their loved ones. But this report reveals there is also a significant economic cost. 'At a time of tight budgets and overstretched services, the Government can't afford to wait any longer. 'The upcoming national cancer plan is an opportunity to transform cancer survival in England. 'Action to prevent more cancers and diagnose them early will give people more moments with those they love, while relieving pressure on the NHS and building a stronger, healthier economy.' As part of its plan, the charity wants the Government to take further action on smoking, obesity and alcohol, all of which contribute to cancer. It also wants to see earlier diagnosis, including fully rolling out lung screening across England, and prioritising research. Annalisa Belloni, lead economist at the charity, said: 'The Government won't deliver growth without delivering for people affected by cancer. 'Dedicating energy and resources to tackling this disease shouldn't be seen as a cost – it's a necessary investment.'

Deaths from cancer cost UK economy £10.3bn every year
Deaths from cancer cost UK economy £10.3bn every year

The Independent

time6 days ago

  • Health
  • The Independent

Deaths from cancer cost UK economy £10.3bn every year

People dying early due to cancer costs the UK economy £10.3 billion every year, according to the most comprehensive analysis of its kind. Researchers from Cancer Research UK calculated the number of working years lost to the disease, alongside people's expected economic output in that time. They found that cancer deaths among young adults aged 25 to 49 are having a significant effect on overall economic output, costing the economy £3.2 billion every year. And when it comes to cancer type, lung cancer accounts for the biggest overall earning loss to the economy of £1.7 billion a year, with 54,000 total productive years of life lost. Bowel cancer accounts for £1.2 billion with 39,000 years lost, while brain cancer accounts for £0.75 billion and 26,000 years, and pancreatic cancer £0.61 billion and 20,000 years. The figures relate to lost earnings and do not include carer costs for looking after people with cancer or the cost of diagnosing or treating the disease. In an accompanying report, Cancer Research UK said improving cancer survival and catching the disease early could boost economic growth. In his foreword to the study, executive director of policy Ian Walker argued that 'cancer isn't just a health challenge, but also an economic one'. He added: 'Current evidence shows that focusing on prevention and early detection and diagnosis is both the right thing to do for people affected by cancer, and the smart thing to do in economic terms.' Overall, each individual adult cancer death was found to cost an average of £61,000 to the economy. The impact was particularly big if people died when younger, owing to the larger loss in terms of working life. In 2023, some 119,000 years were taken from the future working lives of adults under 50, amounting to £3.2 billion in lost output. In the future, losses could grow even more as cancer cases and deaths are projected to rise, with half a million cases diagnosed every year by 2040. Michelle Mitchell, chief executive of Cancer Research UK, said: 'Cancer has an immeasurable impact on patients and their loved ones. 'But this report reveals there is also a significant economic cost. 'At a time of tight budgets and overstretched services, the UK Government can't afford to wait any longer. 'The upcoming national cancer plan is an opportunity to transform cancer survival in England. ' Action to prevent more cancers and diagnose them early will give people more moments with those they love, whilst relieving pressure on the NHS and building a stronger, healthier economy.' As part of its plan, Cancer Research UK wants the Government to take further action on smoking, obesity and alcohol, all of which contribute to cancer. It also wants to see earlier diagnosis, including fully rolling out lung screening across England, and prioritising research. Annalisa Belloni, lead economist at Cancer Research UK, said: 'The UK Government won't deliver growth without delivering for people affected by cancer. 'Dedicating energy and resources to tackling this disease shouldn't be seen as a cost – it's a necessary investment.' The Department of Health has been contacted for comment.

Tennessee football offers 2027 offensive lineman from New Jersey
Tennessee football offers 2027 offensive lineman from New Jersey

Yahoo

time22-06-2025

  • Sport
  • Yahoo

Tennessee football offers 2027 offensive lineman from New Jersey

Tennessee is looking to add to its 2027 football recruiting class. The Vols offered a scholarship to offensive lineman Ian Walker. "After an amazing talk and visit with Glen Elarbee, I am truly blessed to receive an offer from the University of Tennessee," Walker announced. Advertisement The 6-foot-6, 305-pound prospect is from The Pennington School in Pennington, New Jersey. He has not yet accumulated any recruiting rankings from On3, Rivals or 247Sports. Wisconsin was the first school to offer Walker a scholarship on May 14. Other schools to offer Walker a scholarship include Pittsburgh, Boston College and Ohio State. The Vols have nine commitments in their 2026 football recruiting class: quarterback Faizon Brandon, wide receiver Tyreek King, tight end Carson Sneed, offensive lineman Gabriel Osenda, linebacker Braylon Outlaw, defensive lineman C.J. Edwards, defensive lineman Zach Groves, safety K.J. McClain and safety Luke Thompson. Linebacker JP Peace is Tennessee's first 2027 football commitment. Follow Vols Wire on Facebook and X (formerly Twitter). This article originally appeared on Vols Wire: Vols offer scholarship to 2027 offensive lineman from New Jersey

Qualcomm to Buy Alphawave IP for $2.4 Billion
Qualcomm to Buy Alphawave IP for $2.4 Billion

Yahoo

time10-06-2025

  • Business
  • Yahoo

Qualcomm to Buy Alphawave IP for $2.4 Billion

Qualcomm agreed to buy U.K.-listed semiconductor company Alphawave IP Group for about $2.4 billion as it seeks to boost its portfolio of technology used for artificial intelligence, data centers and data storage. The deal concludes two months of talks and will see the U.S. chip maker pay 183 pence a share for the company, a 96% premium to the company's closing price of 93.50 pence on March 31, the day before Qualcomm announced its interest. Warner Discovery Splits Cable From Marquee Streaming, Studio Businesses The Best New Features Coming to Your iPhone, iPad and Mac (and What's Missing) Apple Unveils Array of New Software, but AI Comeback Remains Far Off Think Twice Before You Click 'Unsubscribe' Alexander Brothers File $500 Million Defamation Suit Against The Real Deal On April 1, San Diego-based Qualcomm said it was considering making an offer to buy Alphawave IP Group without disclosing any financial details. Shareholders also have the option of swapping their holding for new Qualcomm shares instead of cash. Alphawave shares jumped 23% to just above the offer price in early trade Monday. 'The combined teams share the goal of building advanced technology solutions and enabling next-level connected computing performance across a wide array of high growth areas, including data-centre infrastructure,' Qualcomm Chief Executive Cristiano Amon said. Alphawave specializes in designing high-speed connectivity technology that enables data to travel faster using lower power. It serves customers in high-growth markets such as data centers, artificial intelligence, 5G wireless infrastructure, data networking, autonomous vehicles and solid-state storage. The company listed in London in 2021 at 410 pence a share but has mostly traded significantly below that level since the initial public offering. The U.K. company's board intends to recommend shareholders accept the deal, which is expected to be completed during the first quarter of 2026. Write to Ian Walker at and Dominic Chopping at Will America's Unbalanced Trade Doom the Dollar? Judge Tosses Justin Baldoni's Lawsuits Against Blake Lively and New York Times The Canned-Food Aisle Is Getting Squeezed by Rising Steel Tariffs WPP CEO to Depart After String of Ad Client Defections Businesses Are Bingeing on Crypto, Dialing Up the Market's Risks Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

British American Tobacco Sells 2.5% Stake in Indian Conglomerate ITC for $1.42 Billion
British American Tobacco Sells 2.5% Stake in Indian Conglomerate ITC for $1.42 Billion

Wall Street Journal

time28-05-2025

  • Business
  • Wall Street Journal

British American Tobacco Sells 2.5% Stake in Indian Conglomerate ITC for $1.42 Billion

British American Tobacco BATS 1.02%increase; green up pointing triangle said it sold a 2.5% shareholding in Indian conglomerate ITC for 1.05 billion pounds ($1.42 billion), more than initially planned. The FTSE 100 cigarette maker–which houses the Kent, Dunhill and Lucky Strike brands–said Wednesday that it completed the sale of 313 million shares in ITC via an accelerated book-build process. The company said on Tuesday that it was planning to sell a 2.3% stake in ITC. BAT, which previously held 25.4% of ITC, reiterated that it will use the money raised to extend its buyback program by an extra 200 million pounds. This will take the total amount to be bought this year to 1.1 billion pounds. The company plans to start the latest part of share buybacks Thursday and expects to complete it by the end of this year. Write to Ian Walker at

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store